High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: A randomized controlled study

C. Dani, V. Vangi, G. Bertini, S. Pratesi, I. Lori, F. Favelli, R. Ciuti, A. Bandinelli, C. Martano, P. Murru, H. Messner, F. Schena, F. Mosca

Research output: Contribution to journalArticlepeer-review

Abstract

Our aim was to assess the hypothesis that a high-dose regimen of ibuprofen is more effective than the standard-dose regimen in closing patent ductus arteriosus (PDA) without increasing adverse effects. Infants of gestational age

Original languageEnglish
Pages (from-to)590-596
Number of pages7
JournalClinical Pharmacology and Therapeutics
Volume91
Issue number4
DOIs
Publication statusPublished - Apr 2012

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: A randomized controlled study'. Together they form a unique fingerprint.

Cite this